Jeffrey R. Baxter's most recent trade in VBI Vaccines Inc. was a trade of 70,000 Option (Right to Buy Common Shares) done . Disclosure was reported to the exchange on July 27, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VBI Vaccines Inc. | Jeffrey R. Baxter | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2023 | 70,000 | 70,000 | - | - | Option (Right to Buy Common Shares) | |
| VBI Vaccines Inc. | Jeffrey R. Baxter | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 100,000 | 100,000 | - | - | Option (Right to Buy Common Shares) | |
| VBI Vaccines Inc. | Jeffrey R. Baxter | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 800,000 | 800,000 | - | - | Option (Right to Buy Common Shares) | |
| Niagen Bioscience Inc. | Jeffrey R. Baxter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 20,000 | 20,000 | - | - | Stock Options (right to buy) | |
| VBI Vaccines Inc. | Jeffrey R. Baxter | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 1,000,000 | 1,000,000 | - | - | Option (Right to Buy Common Shares) |